The content on this site is intended for healthcare professionals only
Dr Matteo Lambertini speaks to ecancer about the young oncologist's perspective of cancer care during the spread of COVID-19 in Italy.
He explains that the pandemic has caused oncologists to alter the way they are treating cancer patients, such as discussing the possibility of treatment delay and prioritising treatment in the early setting as well as treatment in the advanced that is likely to have great benefit.
Dr Lambertini also explains there is an effort to implement a system that allows oral treatment to be administered at home.
He also discusses the implementation of tele medicine for follow up patients and postponing consultations for patients who are showing no sign of disease recurrence.
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours
